Crux Wealth Advisors Ardelyx, Inc. Transaction History
Crux Wealth Advisors
- $235 Billion
- Q2 2025
A detailed history of Crux Wealth Advisors transactions in Ardelyx, Inc. stock. As of the latest transaction made, Crux Wealth Advisors holds 27,393 shares of ARDX stock, worth $142,717. This represents 0.05% of its overall portfolio holdings.
Number of Shares
27,393
Previous 23,273
17.7%
Holding current value
$142,717
Previous $114 Million
6.03%
% of portfolio
0.05%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding ARDX
# of Institutions
229Shares Held
164MCall Options Held
490KPut Options Held
2.35M-
Janus Henderson Group PLC London, X025MShares$130 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$91.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$83.5 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C311.2MShares$58.1 Million0.07% of portfolio
-
State Street Corp Boston, MA10.2MShares$53 Million0.0% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $806M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...